Addressing critical unmet needs in bleeding management

Trauma

Emergency stabilization of hemorrhage improves patient survival following trauma

Hospital

Cost-effective therapy that supports reactive OR proactive treatment for surgical bleeding

Healing

Unique mechanism of action supports and improves overall wound healing outcomes after cessation of bleeding

Safety

Wound-targeting technology minimizes risk of immune or thrombotic complications

Supply Chain

Fast scale-up and easy storage & transport to address critical platelet shortages

REVOLUTIONIZING HEMORRHAGE CONTROL

SymClot: A Novel Therapy to Control Bleeding

SelSym Biotech’s lead product, SymClot, mimics platelet functions to augment hemorrhage control in trauma and surgery and helps to address critical ongoing platelet supply shortages and shelf life limitations

Learn More
PLATFORM TECHNOLOGY

Hemostatic Healing Hydrogels (H3)

SelSym Biotech’s suite of Hemostatic Healing Hydrogels (H3) can be easily tuned to address a wide range of clinical needs in bleeding management and wound healing, including hemorrhage control, drug delivery, infection control, and long-term healing support for chronic wounds

Learn More

Illustrations created using BioRender.com

Interested in partnering with us?

Contact

Connect with SelSym on Social Media!

SelSym on LinkedIn
SelSym on Twitter